Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
!!Link opens in a new tab
!!Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Tricyclic Spirolactones as Modular TRPV1 Synthetic Agonists
Yelena Mostinski
,
Gilad Noy
, Rakesh Kumar
,
Dmitry Tsvelikhovsky
*
,
Avi Priel
*
Corresponding author for this work
School of Pharmacy
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Tricyclic Spirolactones as Modular TRPV1 Synthetic Agonists'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Transient Receptor Potential Vanilloid 1 (TRPV1)
100%
Synthetic Agonists
100%
Spirolactone
100%
Vanilloid
50%
Binding Site
33%
Chemical Species
16%
Molecular Mechanism
16%
Somatosensory System
16%
Therapeutic Approaches
16%
Pain Mechanisms
16%
Small Molecule Inhibitors
16%
Activation Model
16%
Pain Treatment
16%
Pain System
16%
Pain Induction
16%
Molecular Domain
16%
Synthetic Platform
16%
Neuroscience
Agonist
100%
TRPV1
100%
Spironolactone
100%
Binding Site
33%
Somatosensory System
16%
Treatment of Pain
16%
Pain System
16%
Biochemistry, Genetics and Molecular Biology
Agonist
100%
TRPV1
100%
Spironolactone
100%
Binding Site
33%
Small Molecule
16%
Molecular Mechanism
16%
Chemistry
Vanilloid
100%
Spironolactone
100%
Binding Site
66%
Pharmacology, Toxicology and Pharmaceutical Science
Vanilloids
100%
Spironolactone
100%
Binding Site
66%